Equity · Healthcare
CARL
NASDAQCarlsmed (CARL)
The line runs 14 USD on 17 August through 17.15 USD on 13 November, on a scale from 12 to 20. Days the market did not trade hold the previous close, flat.
- Market cap
- 470.0M USD
- P/E (TTM)
- 285.8
- Revenue, year to Dec 2025
- 50.5M USD
- EPS, diluted, year to Dec 2025
- −2.12 USD
- 52-week range
- 8.84 USD – 19.98 USD
- Avg volume
- 6.5K
- Mentions, 30 days
- 16
- Net sentiment
- +0.03
as of Nov 13, 2026
Have Carlsmed (CARL) insiders bought or sold shares recently?
In the 90 days to 15 Nov 2026, Carlsmed insiders reported 4 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 28 Jan 2026, show no open-market purchase.
Form 4, 90 days to 15 Nov 2026, newest reported trade 3 Nov 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 03 Nov 2026 | Bertolini JeffreyChief Operating Officer | Sell | 747 | 11K USD |
| 30 Oct 2026 | Bertolini JeffreyChief Operating Officer | Sell | 243 | 4K USD |
| 05 Oct 2026 | Bertolini JeffreyChief Operating Officer | Sell | 747 | 11K USD |
| 30 Sep 2026 | Bertolini JeffreyChief Operating Officer | Sell | 243 | 3K USD |
| Sold | 4 open-market sales | 1,980 | $29K |
5 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 03 Nov 2026 | Bertolini JeffreyChief Operating Officer | Option exercise | 747 | 4K USD |
| 30 Oct 2026 | Bertolini JeffreyChief Operating Officer | Option exercise | 243 | 542 USD |
| 05 Oct 2026 | Bertolini JeffreyChief Operating Officer | Option exercise | 747 | 4K USD |
| 30 Sep 2026 | Bertolini JeffreyChief Operating Officer | Option exercise | 243 | 542 USD |
| 28 Sep 2026 | Heppenstall RichardCFO, Treasurer | Award | 89,286 |
Which funds hold Carlsmed (CARL)?
0 of the 45 institutional funds we track reported a Carlsmed position for the quarter ended 30 Sep 2026; the latest of those filings landed 13 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Marshall Wace | Exited |
What has been filed or recorded for Carlsmed (CARL)?
The filings we hold for Carlsmed, newest first: 3 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 528 shares | 8K USD notional · 0.002% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 180 shares | 3K USD notional · 0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 2 shares | 28 USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.45 USD | |
| 30 Sep 2026 | Financials | Total assets | 115.3M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 75.7M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.39 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.32 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −2.12 USD | |
| 31 Dec 2025 | Financials | Revenue | 50.5M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −29.6M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −2.12 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.40 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −1.47 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2026 reported | EPS −1.47 USD | |
| 31 Dec 2024 | Annual report | FY 2025 reported | EPS −6.11 USD |
What is Reddit saying about Carlsmed (CARL)?
Reddit mentioned CARL 16 times in the 30 days to 15 November 2026, across 2 of the communities we track. All of them were scored for sentiment: 44% read bullish, 19% bearish and 37% neither. Reddit data updated 15 November 2026.
30-day window, Method
How do Reddit mentions of Carlsmed (CARL) compare with its price?
Share ↗
Which subreddits are talking about Carlsmed (CARL)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 94% | 15 | +0.03 |
| r/stocks | 6% | 1 | +0.08 |
Which names move with Carlsmed (CARL) on Reddit?
LLY moved most closely with Carlsmed (CARL): when the crowd talked about one, it talked about the other (+0.71 over 31 days). Co-discussion, not price.
CARL | +0.71 | +0.67 | +0.67 | +0.67 | +0.66 | +0.64 |
|---|
View the matrix as a tableHide the table
| Pair | Match | Days measured |
|---|---|---|
| CARL and LLY | +0.71 | 31 days |
| CARL and WS | +0.67 | 31 days |
| CARL and TILE | +0.67 | 31 days |
| CARL and LAD | +0.67 | 31 days |
| CARL and BNB | +0.66 | 31 days |
| CARL and EBAY | +0.64 | 31 days |
What do people ask about Carlsmed (CARL)?
What did Carlsmed shares close at?17.15
Carlsmed closed at 17.15 USD on 13 Nov 2026, down 0.87% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Carlsmed’s market cap?470.0M
Carlsmed is worth 470.0M USD by market value as of 13 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Carlsmed’s P/E ratio?285.8
Carlsmed has a price-to-earnings ratio of 285.8, as of 13 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Carlsmed’s revenue?50.5M
Carlsmed reported revenue of 50.5M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Carlsmed insiders bought or sold shares recently?4 sales
In the 90 days to 15 Nov 2026, Carlsmed insiders reported 4 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 28 Jan 2026, show no open-market purchase. A further 5 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Carlsmed?0 of 45
0 of the 45 funds we track reported a Carlsmed position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Marshall Wace. See Funds
When did Carlsmed last report earnings?−0.45
Carlsmed last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.45 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Carlsmed?2 mentions
Carlsmed was mentioned 2 times in the last 7 days across the finance subreddits we track, and 16 times over the trailing 30 days. Of the 16 mentions scored for sentiment, 44% read bullish and 19% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings